Key result
Mitral valve repair for mitral restenosis after percutaneous balloon mitral valvotomy significantly increased mean mitral valve area from 1.16 cm2 to 1.62 cm2, with a 5-year event-free survival of 56.16%.
Why the study?
Does mitral valve repair improve outcomes in patients with symptomatic mitral valve restenosis after percutaneous balloon mitral valvotomy?
Observational (n=15)
No
Does mitral valve repair improve outcomes in patients with symptomatic mitral valve restenosis after percutaneous balloon mitral valvotomy?
Mitral valve repair for restenosis after percutaneous balloon mitral valvotomy improves valve hemodynamics but has a modest 5-year event-free survival of 56.16%, suggesting it may not be a definitive alternative to replacement for all patients.
Answers are grounded in this paper and cite their sources.
May improve hemodynamics in selected cases; leaves open whether repair outperforms replacement for post-valvotomy restenosis.
BACKGROUND: There have been a number of studies on mitral valve replacement and repeated percutaneous mitral balloon valvotomy for mitral valve restenosis after percutaneous mitral balloon valvotomy. However, studies on mitral valve repair for these patients are rare. In this study, we analyzed postoperative outcomes of mitral valve repair for mitral valve restenosis after percutaneous mitral balloon valvotomy. METHODS: In this study, we assessed 15 patients (mean age, 47.7±9.7 years; 11 female and 4 male) who underwent mitral valve repair between August 2008 and March 2013 for symptomatic mitral valve restenosis after percutaneous mitral balloon valvotomy. The mean interval between the initial percutaneous mitral balloon valvotomy and the mitral valve repair was 13.5±7 years. The mean preoperative Wilkins score was 9.4±2.6. RESULTS: The mean mitral valve area obtained using planimetry increased from 1.16±0.16 cm(2) to 1.62±0.34 cm(2) (p=0.0001). The mean pressure half time obtained using Doppler ultrasound decreased from 202.4±58.6 ms to 152±50.2 ms (p=0.0001). The mean pressure gradient obtained using Doppler ultrasound decreased from 9.4±4.0 mmHg to 5.8±1.5 mmHg (p=0.0021). There were no early or late deaths. Thromboembolic events or infective endocarditis did not occur. Reoperations such as mitral valve repair or mitral valve replacement were not performed during the follow-up period (39±16 months). The 5-year event-free survival was 56.16% (95% confidence interval, 47.467-64.866). CONCLUSION: On the basis of these results, we could not conclude that mitral valve repair could be an alternative for patients with mitral valve restenosis after percutaneous balloon mitral valvotomy. However, some patients presented with results similar to those of mitral valve replacement. Further studies including more patients with long-term follow-up are necessary to determine the possibility of this application of mitral valve repair.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2015) conducted an observational in Symptomatic mitral valve restenosis after percutaneous mitral balloon valvotomy (n=15). Mitral valve repair vs. Preoperative baseline was evaluated on Mean mitral valve area (cm2) (p=0.0001). Mitral valve repair for mitral restenosis after percutaneous balloon mitral valvotomy significantly increased mean mitral valve area from 1.16 cm2 to 1.62 cm2, with a 5-year event-free survival of 56.16%.
Synapse has enriched 10 related papers. Consider them for comparative context: